Signals Inbox·August 21, 2026·Defense Tech

Is Cambridge Aerospace really worth $3.4B today?

Yes, Cambridge Aerospace’s $3.4B valuation looks aggressive but plausible today: the financial proof is still thin, but government procurement, planned missile capacity and a fast-expanding industrial footprint give the company a credible route to growing into it.

Q1Is Cambridge Aerospace really worth $3.4B today?

Yes, $3.4 billion looks aggressive but plausible today, provided Cambridge Aerospace turns its early government wins into several hundred million dollars of annual revenue fairly quickly.

The company has done a remarkable amount in less than two years. Skyhammer has moved into UK procurement, the Ministry of Defence has tested the interceptor in Jordan, Cambridge is working with the US Army, and the company is already expanding manufacturing outside Britain through a deal with Kawasaki Heavy Industries in Japan. Investors are buying into a company that has moved well beyond the prototype stage.

The problem is the financial evidence. Cambridge does not disclose annual revenue, gross margins or unit economics. The best commercial figure we found is a Resilience Media report, based on correspondence it obtained, saying Cambridge had more than $140 million of signed contracts and roughly $5 billion of pipeline. Useful numbers, certainly, but neither tells us what Cambridge currently books as annual revenue.

The valuation starts to make sense once we work backwards. At 20x revenue, Cambridge needs around $170 million of annual sales. At 10x, it needs $340 million. Those levels are high for a company this young, yet they no longer look absurd when compared with the valuations investors are paying for Anduril, Helsing, Saronic and, most recently, missile manufacturer Castelion.

Our starting judgment is fairly sharp. Cambridge has not yet published the financial results that would make $3.4 billion look comfortable. It has, however, built enough product, customer and manufacturing momentum for us to see a credible route to earning that valuation.

Q2How did Cambridge Aerospace reach $3.4B so quickly?

Cambridge Aerospace went from roughly $400 million to $3.4 billion in about a year, an 8.5x increase that stands out even in today's overheated defence-tech market.

Bloomberg reported in 2025 that Cambridge had raised around $100 million at roughly a $400 million valuation. Four months before the latest round, the company raised another $200 million at $1.3 billion. The newest Series C brought in $300 million at a $3.4 billion post-money valuation, led by DFJ Growth, with Lux, Accel, Lakestar, Never Lift, Ora Global and Elad Gil also participating.

The jump from $1.3 billion to $3.4 billion in four months is 2.6x. Going back to the roughly $400 million mark, the company became 8.5 times more valuable in around a year.

Cambridge also reached that figure extraordinarily young. Companies House records show that Cambridge Aerospace was incorporated on September 4, 2024. It reached multibillion-dollar status before its second anniversary. Anduril, by comparison, had been operating for around nine years when it reached $61 billion. Helsing had been around for roughly five years when it reached $18 billion.

The Series C was $300 million, so the implied pre-money valuation was around $3.1 billion. In other words, investors valued the business before their new cash at roughly 2.4 times its entire $1.3 billion post-money valuation from just four months earlier. That is the part of the funding history we find most striking.

Cambridge Aerospace valuation history

Q3Did Cambridge Aerospace earn that valuation jump, or is this mostly defence-tech hype?

Cambridge earned part of the jump through real execution, but an 8.5x increase in around a year also reflects how aggressively investors are repricing defence companies these days.

Around the earlier funding rounds, Cambridge was still a very young developer of interceptors. Since then, Skyhammer has entered government procurement. The UK Ministry of Defence announced a multi-million-pound agreement covering interceptors, launchers, integration, technical support and operator training. The system was subsequently tested in Jordan, and the Financial Times has reported US Army testing as well.

Cambridge has also widened the industrial footprint behind the product. The company is building a large solid-rocket-motor facility in Norfolk and has begun expanding internationally. These are much harder milestones than publishing another demo video or announcing a memorandum of understanding.

Still, the valuation moved faster than the public operating data. Helsing recently reached $18 billion, Quantum Systems roughly $8 billion, Anduril $61 billion and Castelion $13 billion. Cambridge improved quickly at exactly the moment investors became willing to pay far more for future defence revenue.

Q4How much revenue does Cambridge Aerospace actually make, and what multiple are investors paying?

We still cannot verify Cambridge Aerospace's annual revenue, and that makes any exact current revenue multiple impossible to defend.

Cambridge is private and has not disclosed a current revenue figure. Its UK accounts do not yet give us a useful view of the business at its present scale either. ARR would also be a poor metric here because Cambridge sells physical defence systems and related services rather than recurring software subscriptions.

The strongest commercial number we found came from Resilience Media. Based on correspondence it obtained, the publication reported more than $140 million of signed contracts and around $5 billion of opportunities in the pipeline.

We should be careful with the $140 million figure. Contract value can be recognized over several years, and contracts may include launchers, integration, training and support alongside interceptors. Official sources confirm that money is genuinely changing hands, but they do not disclose enough to rebuild Cambridge's income statement.

One rough reference point is the reported contract book. A $3.4 billion valuation is roughly 24 times $140 million. We would never call that a 24x revenue multiple, since signed contract value and annual revenue are different things, but it shows how much future delivery investors are already capitalizing.

The better test is the revenue Cambridge eventually needs. At $170 million of annual sales, $3.4 billion equals 20x revenue. At $227 million it becomes 15x. At $340 million it falls to 10x.

For now, Cambridge has meaningful commercial traction but no reliable public revenue number. Investors are effectively betting that sales reach the hundreds of millions soon.

Q5Does Cambridge Aerospace look ridiculously expensive next to Lockheed Martin and RTX?

Yes, Cambridge looks extremely expensive beside public defence companies, although its faster growth deserves a substantial premium.

Stock Analysis currently puts Lockheed Martin at around 1.8x trailing revenue, Northrop Grumman near 1.9x and RTX around 3.2x. Their trailing revenue growth is roughly 7%, 6% and 12% respectively.

Put Cambridge at a hypothetical $170 million of annual revenue and its valuation would still equal 20x sales. That would be roughly six to eleven times the sales multiples of those public companies.

The comparison becomes less shocking when you look at what investors are buying. Lockheed generated about $77 billion of trailing revenue and grows in the single digits. Cambridge is starting from a tiny base and could plausibly multiply revenue very quickly if procurement expands.

The public-company comparison is therefore most useful as a long-term constraint: Cambridge has to grow into the current price before its multiple compresses toward normal defence levels.

Q6Is Cambridge Aerospace expensive even compared with defence-tech startups?

Cambridge looks expensive, but it no longer looks bizarre beside the valuations private investors are paying for defence-tech companies now.

Anduril is the clearest reference point. The company raised $5 billion at a $61 billion valuation after saying 2025 revenue had doubled to $2.2 billion. That works out to roughly 28x trailing revenue. Anduril is far more proven than Cambridge, but the deal shows how high investors will go for a company they believe can become a new defence prime.

Helsing provides an even closer European benchmark. Its latest funding valued the company at $18 billion. The Financial Times estimated that figure at about 32x projected 2026 revenue of €441 million and explicitly reported concerns among investors that the price might reflect a defence-tech bubble.

Quantum Systems sits at the other end of the range. Its latest round valued it near $8 billion while the company expected more than €700 million of revenue and around €200 million of EBITDA. The Financial Times put its multiple at approximately 8.5x. Cambridge has nowhere near that level of disclosed financial proof.

Then there is Castelion. The missile manufacturer has just raised $800 million at a $13 billion post-money valuation according to Axios, while the Wall Street Journal reported the broader Series C financing at more than $1 billion. Castelion's rise is especially relevant because it shows that huge private valuations have now moved from defence software and drones into missile manufacturing.

Cambridge lands in an unusual middle ground: its valuation has plenty of precedent, but Anduril, Quantum and Helsing give investors much more financial or programme-level evidence.

Cambridge Aerospace versus defence-tech peers

Q7Is Cambridge Aerospace actually growing fast enough?

Operationally, Cambridge is moving unusually fast; the missing piece is whether revenue is compounding at the same pace.

The company was incorporated in late 2024. By the following spring it had gone from relative obscurity to a UK government Skyhammer order. That procurement called for the first deliveries within weeks rather than years, which is unusual for a new defence supplier.

Hiring followed the same trajectory. A UK government announcement earlier this year referred to 125 existing Cambridge Aerospace jobs and plans for more. By the latest financing, Steven Barrett told the Financial Times that the company employed around 250 people, with a large share in technical and engineering roles.

International expansion is also happening much earlier than we would normally expect for a company this young. Cambridge now has activity across several European countries and Australia, while the Japanese manufacturing partnership takes it into another major allied defence market.

Cambridge is genuinely scaling. What we cannot yet say is that revenue doubled or tripled alongside headcount and manufacturing ambition. That distinction keeps us from calling the valuation fully proven.

Q8What do Cambridge Aerospace’s $140M of contracts and $5B pipeline really tell us?

The reported $140 million contract book is meaningful, while the $5 billion pipeline deserves much more skepticism.

Signed defence contracts tell us that customers have moved past curiosity and into procurement. For a company less than two years old, more than $140 million of reported contracted business would be substantial. It also fits with the official evidence we can independently see: UK procurement, subsequent Ministry of Defence work and multinational interceptor programmes.

The pipeline is a much softer number. According to Resilience Media, Cambridge had around $5 billion of opportunities under consideration. That is roughly 36 times the reported contract book.

A ratio that large is exciting because it shows the potential market around Cambridge, but it also tells us how much of the commercial story has yet to convert. Government opportunities can be delayed, resized, split among suppliers or lost entirely.

The multinational low-cost interceptor programme gives us a good example. Cambridge was selected alongside Frankenburg Technologies and Greenjets under contracts collectively worth £3.16 million. Being inside the programme is valuable, yet Cambridge still has competitors trying to win the same future budgets.

We put far more weight on growth in signed contracts than on growth in pipeline. If Cambridge turns even a modest share of that $5 billion into funded orders, the valuation will look considerably stronger.

Q9Is Skyhammer actually cheap and effective enough to change air defence?

Skyhammer could materially improve air-defence economics if its reported cost and performance hold up outside early deployments.

The problem Cambridge is attacking is very real. Militaries can end up using interceptors worth hundreds of thousands or even more than $1 million against incoming drones that cost a fraction of that amount. Repeating that exchange at scale drains missile inventories and budgets quickly.

Cambridge has not published an official Skyhammer price list. Resilience Media cited estimates around $20,000 to $50,000 per interceptor. If the real delivered price lands anywhere near that range, Skyhammer could bring the cost of defending against Shahed-style drones much closer to the cost of the attacking weapon.

Performance is the other half of the equation. At Eurosatory, co-founder Chris Sylvan told Janes that Skyhammer had achieved around 70% effectiveness across the totality of Cambridge's activity. The Ministry of Defence has separately announced successful testing in Jordan, which gives us some independent evidence that the system works well enough to move into procurement.

We still lack the dataset needed to turn 70% into a reliable combat kill probability. We do not know the full mix of targets, environmental conditions, electronic warfare, firing doctrine or how many interceptors were used per engagement.

For the valuation, Cambridge's whole economic proposition depends on producing a cheap interceptor that works reliably enough at scale. That is still being proven.

Q10Does producing 2,500 Skyhammers a month make $3.4B reasonable?

Yes. If Cambridge reaches 2,500 Skyhammers a month and customers absorb even part of that output, the $3.4 billion valuation becomes much easier to explain.

The Financial Times says Cambridge wants to reach that monthly production rate by March 2027. Annualized, it would mean capacity for about 30,000 interceptors.

Using the reported $20,000 to $50,000 unit-price range only as a scenario, full utilization would correspond to $600 million to $1.5 billion of annual Skyhammer sales. We should not treat those figures as forecasts: price is unconfirmed, the ramp may take time, and manufacturing capacity is useless without orders.

What interests us more is the amount of capacity Cambridge needs to fill. At $50,000 per interceptor, $170 million of annual sales requires 3,400 units. At $20,000, it requires 8,500. Those numbers represent roughly 11% to 28% of planned annual capacity.

At $340 million of sales, Cambridge would need about 6,800 to 17,000 units, equivalent to roughly 23% to 57% of planned capacity.

That is one of the strongest arguments in favour of the valuation. Cambridge does not need every production line running flat out for the revenue numbers to start supporting $3.4 billion.

Q11Is the air-defence market growing fast enough for Cambridge Aerospace?

Yes, European defence demand is growing fast enough to support a multibillion-dollar supplier if Cambridge can capture a meaningful share.

The latest European Defence Agency data show EU member states spent €418 billion on defence in 2025, 20% more than the previous year. Spending is expected to rise again to €454 billion in 2026.

The longer trend is even stronger. The European Council calculates that 2026 spending is 75.3% higher than in 2021. Defence investment is expected to reach almost €163 billion, up 158.7% over the same five-year period.

These budgets also appear to be shifting toward exactly the capabilities Cambridge sells. Equipment procurement reached €115 billion in 2025, while governments are setting up specific low-cost interceptor programmes after watching large numbers of cheap drones consume much more expensive air-defence ammunition in Ukraine and the Middle East.

This spending cycle has already lasted several years. Cambridge has a large enough market around it; the harder question is how much of it the company can capture.

Q12What can Cambridge Aerospace do that competitors cannot easily copy?

Cambridge is building a credible advantage around manufacturing, propulsion and procurement, although competitors can still attack every layer of the product.

Skyhammer itself is only part of the picture. Cambridge is also developing Starhammer for faster threats, Looking Glass radar technology and Nightstar solid rocket motors. The Financial Times reports that the company is building what it describes as Europe's largest solid-rocket-motor facility in Norfolk.

Owning propulsion matters because rocket motors are a bottleneck across Western missile manufacturing. Producing more of them internally could give Cambridge greater control over cost, lead times and product iteration. The same capacity could eventually serve customers beyond Cambridge's own interceptors, although we have not found evidence of meaningful third-party motor revenue yet.

The latest Kawasaki Heavy Industries partnership adds another interesting layer. Cambridge has agreed to develop manufacturing capability in Japan with one of the country's major industrial groups. For such a young company, getting a partner of that scale to work on local production is stronger evidence than opening another sales office abroad.

Government integration can also create stickiness. Once a military has tested an interceptor, trained operators, integrated launchers and support systems, and built procurement around it, switching suppliers becomes more painful.

None of this gives Cambridge monopoly power. Frankenburg and Greenjets are already competing in the UK's multinational low-cost-interceptor work, while companies such as Epirus attack the drone problem using high-power microwave systems. Lasers, electronic warfare and legacy missile manufacturers cover other layers of the same air-defence stack.

Cambridge's strongest advantage currently looks like speed: getting affordable hardware designed, tested, procured and manufactured faster than traditional suppliers. The moat becomes much stronger if it can keep that speed at industrial scale.

Q13Is Cambridge Aerospace trying to become the next Anduril?

Cambridge is starting to look like a small air-defence prime, but calling it the next Anduril today would be several years early.

The product roadmap already goes beyond one interceptor. Skyhammer covers drones and cruise-missile-type threats. Starhammer is intended for faster threats such as ballistic missiles. Looking Glass adds radar, while Nightstar moves Cambridge deeper into propulsion.

That creates the beginnings of a full air-defence stack rather than a one-product startup. Steven Barrett has also told the Financial Times that acquisitions could eventually help Cambridge expand, which sounds much closer to the strategy of an emerging prime than that of a narrow component manufacturer.

There is also a direct connection in the founding team: co-founder Chris Sylvan previously worked at Anduril after serving in the Royal Marines.

The scale difference remains huge. Anduril has around nine years of operating history, generated $2.2 billion of revenue last year and sells across sensors, drones, autonomy software, counter-drone systems, aircraft and other defence categories. Cambridge's public commercial history is measured in months.

Anduril is a useful map of what the bull case could become. Investors are already paying Cambridge as if it has a chance of building a much broader defence company. The next few years will tell us whether that is foresight or simply paying for the destination too early.

Q14What revenue does Cambridge Aerospace need to justify $3.4B?

Cambridge needs roughly $113 million to $340 million of annual revenue to support $3.4 billion at 30x to 10x sales, with the $170 million to $340 million range looking most useful to us.

A 30x multiple would require only $113 million of annual revenue, but we would consider that an extreme valuation unless growth remained exceptional. Helsing's current valuation shows that investors will pay around that level, though the Financial Times has already reported concern that such pricing may represent a bubble.

At 20x, Cambridge needs $170 million. At 15x, about $227 million. At 10x, $340 million.

As seen above, Cambridge's planned annualized Skyhammer capacity gives those numbers some industrial context. Even under the lower end of the reported pricing range, the company would not necessarily need full factory utilization to get into the revenue band that begins to support today's valuation.

The harder test comes later. At a 5x multiple, Cambridge needs $680 million of annual revenue. That is why the broader portfolio matters. A mature $3.4 billion Cambridge probably needs Starhammer, propulsion, radar or other products alongside Skyhammer.

Revenue needed to justify a $3.4B valuation

Q15What has to go right for Cambridge Aerospace’s valuation to work?

The bull case works if Cambridge turns its early government wins into repeat orders while manufacturing scales without destroying cost or reliability.

The first requirement is commercial repetition. One country buying Skyhammer proves that procurement is possible. Multiple countries ordering it again and again would prove that Cambridge has a real franchise.

The second is manufacturing. Investors have given Cambridge hundreds of millions of dollars largely because demand for weapons is running ahead of Western production capacity. Cambridge has to show that a young company can actually manufacture missiles faster and more cheaply than the organisations it is trying to disrupt.

Product expansion comes next. Starhammer needs to move from development into procurement, and the propulsion business needs to become an advantage rather than simply another expensive factory to operate.

Finally, Cambridge has to preserve the economics that make Skyhammer attractive. A low-cost interceptor loses much of its appeal if scaled manufacturing, testing, electronics or propulsion push the delivered price sharply higher.

If those pieces line up, Cambridge can reach the revenue levels needed to make today's valuation much easier to defend.

Q16What could make Cambridge Aerospace’s $3.4B valuation fall apart?

The valuation becomes vulnerable very quickly if manufacturing slips, contract conversion disappoints or investors stop paying enormous multiples for defence startups.

Manufacturing is probably the biggest operating risk. Building thousands of interceptors requires repeatable suppliers, motors, electronics, quality control, acceptance testing and working capital. Hardware scaling can expose problems that never appear when a company produces dozens or hundreds of units.

Customer concentration is another risk. Cambridge's visible procurement success is currently heavily tied to government defence programmes. Orders can move quickly during a crisis and then slow when budgets, politics or procurement priorities change.

Technical performance still needs deeper independent validation too. The roughly 70% effectiveness figure reported by Janes is encouraging, but Cambridge will eventually be judged on larger operational datasets and tougher environments.

Competition can also squeeze pricing. Militaries will probably use a mix of kinetic interceptors, electronic warfare, microwaves, lasers and traditional missiles rather than choose one universal counter-drone system.

And then there is valuation risk itself. Cambridge could execute reasonably well and still disappoint investors if private defence multiples fall. A company valued at 20x revenue can lose half its value simply by being repriced to 10x, even if revenue continues growing.

Cambridge has already shown that investors want to fund it. The next test is whether contracts and deliveries can scale just as quickly.

Q17So is Cambridge Aerospace really worth $3.4B today?

Yes, $3.4 billion is plausible today, but Cambridge has not yet earned that valuation on disclosed financial fundamentals.

The bearish case is easy to understand. Cambridge does not publish annual revenue. We cannot verify gross margins or scaled unit economics. A large part of the company's manufacturing capacity is still being built, and several important products remain in development. Investors have priced in a lot of success before they can see it in an income statement.

Still, the evidence is stronger than we normally see in a two-year-old hardware startup. Cambridge has gone from incorporation to government procurement at remarkable speed. It has already crossed into international testing and manufacturing partnerships. Its product addresses a cost problem militaries urgently want to solve, while European defence budgets and equipment spending are climbing sharply.

The private-market comparisons also change the answer. Anduril, Helsing, Quantum Systems and Castelion show that investors currently place very high values on companies capable of adding scarce Western defence capacity. Cambridge sits squarely inside that trade.

The numbers give us the final test. Cambridge needs around $170 million of annual revenue for a 20x multiple and $340 million for 10x. Those are demanding targets for such a young company, but they are realistic enough that we can map a path from current procurement to that scale.

The conclusion is aggressive but plausible. Cambridge Aerospace is being valued several steps ahead of the financial evidence, and anyone paying $3.4 billion today is betting heavily on execution. Yet the company has already produced enough real-world progress that the bet is grounded in more than defence-tech excitement.

If contract value keeps climbing, international customers follow the UK, manufacturing reaches meaningful scale and the broader product portfolio starts selling, Cambridge can grow into $3.4 billion. If revenue remains modest while the factories and product roadmap stay mostly prospective, the valuation will look stretched very quickly.